Todays historic announcement marks an important step toward the FDAs goal of reducing preventable disease and death caused by
tobacco, said FDA Commissioner Margaret A. Hamburg, M.D. The FDA has unprecedented responsibility to protect public health by not allowing new
tobacco products under FDAs authority to come to market without FDA review.
Todays decisions are just the first of many forthcoming product review actions to be issued, said Mitch Zeller, J.D., director of the FDA's Center for Tobacco Products.
The FDA is committed to making science-based decisions on all product applications and providing the agencys scientific rationale behind its actions to ensure the most transparent and efficient process possible for all involved parties, according to the law.